Abstract
Background The use of oral complementary and alternative medicines, including herbal supplements, has been increasing in pregnant women worldwide despite limited safety data. The decision of healthcare professionals to recommend these products to pregnant patients is controversial and not well documented. Objective To explore the recommendations and information sources that healthcare professionals use to determine the safety of oral non-prescribed supplements during pregnancy. Setting An Australian metropolitan maternity hospital. Method An electronic survey was distributed to doctors, midwives, pharmacists, dietitians, lactation consultants and physiotherapists. Main outcome measure The nature of recommendations and information sources that healthcare professionals use to determine the safety of oral non-prescribed supplements during pregnancy. Results Responses were received from 54 healthcare professionals. Forty of 54 (74.1%) were concerned about the safety of their patients’ supplements, while 35 of 54 (64.8%) felt that they had access to trustworthy safety information. Supplements most commonly recommended as safe to use were ginger (40.7%), probiotics (29.6%) and raspberry leaf (22.2%). Participants specifically requested further safety information for raspberry leaf, evening primrose oil, fish oil, probiotics, ginger, vitamin C, valerian, turmeric, blue cohosh and colloidal silver. Written resources most frequently consulted included MIMS® (61.1%) and ‘Google Searches’ (29.6%), and healthcare professionals most referred to were pharmacists (74.1%), doctors (22.2%), and naturopaths or herbalists (3.7%). Conclusion The recommendations of maternity heath care professionals and quality of information sources used varied. Further education and access to unbiased safety information is required to empower healthcare professionals to provide informed recommendations to pregnant patients.
Similar content being viewed by others
References
World Health Organisation. Traditional medicine: definitions. In: The World Health Organisation, Geneva. 2017. http://www.who.int/medicines/areas/traditional/definitions/en/. Accessed 13 Nov 2017.
Reid R, Steel A, Wardle J, Trubody A, Adams J. Complementary medicine use by the Australian population: a critical mixed studies systematic review of utilisation, perceptions and factors associated with use. BMC Complement Altern Med. 2016;16:176.
Forster DA, Denning A, Wills G, Bolger M, McCarthy E. Herbal medicine use during pregnancy in a group of Australian women. BMC Pregnancy Childbirth. 2006;6:21.
Vickers KA, Jolly KB, Greenfield SM. Herbal medicine: women’s views, knowledge and interaction with doctors: a qualitative study. BMC Complement Altern Med. 2006;6:40.
Boltman-Binkowski H. A systematic review: Are herbal and homeopathic remedies used during pregnancy safe? Curationis. 2016;39:1514.
Raynor DK, Dickinson R, Knapp P, Long AF, Nicholson DJ. Buyer beware? Does the information provided with herbal products available over the counter enable safe use? BMC Med. 2011;9:94.
Blitz MJ, Smith-Levitin M, Rochelson B. Severe hyponatremia associated with use of black cohosh during prolonged labor and unsuccessful home birth. AJP Rep. 2016;6:e121–4.
Cayan F, Dilek U, Akbay E, Gen R, Dilek S. Use of Chinese herbal medicine ‘meizitanc’ in pregnancy: report of three cases. J Obstet Gynaecol Res. 2009;35:801–3.
Jones TK, Lawson BM. Profound neonatal congestive heart failure caused by maternal consumption of blue cohosh herbal medication. J Pediatr. 1998;132:550–2.
Singla M, Sahai V, Grewal DS. Neural tube defects and herbal medicines containing lead: a possible relationship. Med Hypotheses. 2009;72:285–7.
Wong A, Dargan P, Koutsogiannis Z, Sokol J, Ramkrishna J, Greene SL. Chronic ayurvedic medicine use associated with major and fatal congenital abnormalities. Med J Aust. 2015;203:443–4.
Yusof J, Mahdy ZA, Noor RM. Use of complementary and alternative medicine in pregnancy and its impact on obstetric outcome. Complement Therap Clin Pract. 2016;25:155–63.
Kennedy DA, Lupattelli A, Koren G, Nordeng H. Safety classification of herbal medicines used in pregnancy in a multinational study. BMC Complement Altern Med. 2016;16:102.
Nature’s Synergy Pty Ltd. FLORADIX formula liquid herbal iron extract. In: Floradix®. Nature’s Synergy Pty Ltd. http://floradix.com.au/Floradix/Floradix-Iron-and-Herbs-250ml/16.html. Accessed 13 Nov 2017.
Bent S. Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center. J Gen Intern Med. 2008;23:854–9.
Vagg M. Supplement regulation by TGA is completely cactus. In: AMA: Australian Medical Association. 2013. https://ama.com.au/ausmed/supplement-regulation-tga-completely-cactus. Accessed 13 Nov 2017.
Ginger, probiotics, raspberry leaf [monographs]. In: Natural medicines comprehensive database. 2016. https://naturalmedicines.therapeuticresearch.com/. Accessed 1 Feb 2018.
Ding M, Leach M, Bradley H. The effectiveness and safety of ginger for pregnancy-induced nausea and vomiting: a systematic review. Women Birth. 2013;26:e26–30.
Heitmann K, Nordeng H, Holst L. Safety of ginger use in pregnancy: results from a large population-based cohort study. Eur J Clin Pharmacol. 2013;69:269–77.
Vutyavanich T, Kraisarin T, Ruangsri R. Ginger for nausea and vomiting in pregnancy: randomized, double-masked, placebo-controlled trial. Obstet Gynecol. 2001;97:577–82.
Elias J, Bozzo P, Einarson A. Are probiotics safe for use during pregnancy and lactation? Can Fam Physician. 2011;57:299–301.
Probiotics [monographs]. In: MIMS online. 2017. https://www.mimsonline.com.au/. Accessed 13 Nov 2017. Subscription required to view.
Allen SJ, Jordan S, Storey M, Thornton CA, Gravenor M, Garaiova I, et al. Dietary supplementation with lactobacilli and bifidobacteria is well tolerated and not associated with adverse events during late pregnancy and early infancy. J Nutr. 2010;140:483–8.
Dugoua JJ, Machado M, Zhu X, Chen X, Koren G, Einarson TR. Probiotic safety in pregnancy: a systematic review and meta-analysis of randomized controlled trials of Lactobacillus, Bifidobacterium, and Saccharomyces spp. J Obstet Gynaecol Can. 2009;31:542–52.
Luoto R, Laitinen K, Nermes M, Isolauri E. Impact of maternal probiotic-supplemented dietary counselling on pregnancy outcome and prenatal and postnatal growth: a double-blind, placebo-controlled study. Br J Nutr. 2010;103:1792–9.
McFarlin BL, Gibson MH, O’Rear J, Harman P. A national survey of herbal preparation use by nurse-midwives for labor stimulation. Review of the literature and recommendations for practice. J Nurse Midwifery. 1999;44:205–16.
Holst L, Haavik S, Nordeng H. Raspberry leaf–should it be recommended to pregnant women? Complement Ther Clin Pract. 2009;15:204–8.
Simpson M, Parsons M, Greenwood J, Wade K. Raspberry leaf in pregnancy: its safety and efficacy in labor. J Midwifery Womens Health. 2001;46:51–9.
Wang L, Wang J, Wang M, Li Y, Liang Y, Xu D. Using Internet search engines to obtain medical information: a comparative study. J Med Internet Res. 2012;14:e74.
Day RO, Snowden L. Where to find information about drugs. Australian prescriber. 2016;39:88–95.
Ernst E. Herbal medicinal products during pregnancy: Are they safe? BJOG. 2002;109:227–35.
Drug and Therapeutics Bulletin. Herbal medicines—What do clinicians know? Drug Ther Bull. 2010;48:46–7.
Acknowledgements
Study investigators would like to acknowledge the Medicines Information Service of the Royal Women’s Hospital pharmacy department for their input.
Funding
No funding has been received for this study or the preparation of this manuscript except for ordinary wages.
Conflicts of interest
The authors do not have any conflict of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Gilmartin, C.E., Vo-Tran, TH. & Leung, L. Complementary medicines in pregnancy: recommendations and information sources of healthcare professionals in Australia. Int J Clin Pharm 40, 421–427 (2018). https://doi.org/10.1007/s11096-018-0608-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-018-0608-x